metastasis

send to a friend share this

Transcriptome Reprogramming of CD11b+ Bone Marrow Cells by Pancreatic Cancer Extracellular Vesicles

O cancro de pâncreas é a quarta principal causa de mortes relacionadas ao cancro no mundo, apresentando uma taxa de sobrevida de 5 anos de cerca de 6% e uma taxa de sobrevida média de cerca de 6 meses. Entre os cancros pancreáticos, o adenocarcinoma ductal pancreático (CP) é o tipo mais comum e é responsável por mais de 90% dos casos. Uma combinação de fatores leva ao mau prognóstico do CP, incluindo dificuldades na deteção da doença em estágio inicial, seu alto potencial metastático e sua resistência às terapias convencionais.

Hybrid epithelial-mesenchymal phenotypes are controlled by microenvironmental factors

23rd International Symposium on Molecular Medicine

Tawana Hotel, Conference Centre, Bangkok, Thailand

 

28 - 30 March, 2019

 

See more informations here: http://worldacademyofsciences.com/thailand.html

23rd International Symposium on Molecular Medicine

Tawana Hotel, Conference Centre, Bangkok, Thailand

 

28 - 30 March, 2019

 

See more informations here: http://worldacademyofsciences.com/thailand.html

Aberrant Glycosylation in Cancer: A Novel Molecular Mechanism Controlling Metastasis – PREVIEW

Major alterations in cell glycosylation occurring during cancer development and progression represent key features of tumor cell malignant behavior. In this publication, the authors preview and put in context the findings of Agrawal et al. (Cancer Cell, Vol. 31, Issue 6, 2017) that identified and characterized a novel molecular mechanism in which aberrant glycosylation actively tunes the metastatic capacity of melanoma cells by preventing the proteolytic cleavage of the L1CAM adhesion molecule.

 

Authors and Affiliations:

Aberrant Glycosylation in Cancer: A Novel Molecular Mechanism Controlling Metastasis – PREVIEW

Major alterations in cell glycosylation occurring during cancer development and progression represent key features of tumor cell malignant behavior. In this publication, the authors preview and put in context the findings of Agrawal et al. (Cancer Cell, Vol. 31, Issue 6, 2017) that identified and characterized a novel molecular mechanism in which aberrant glycosylation actively tunes the metastatic capacity of melanoma cells by preventing the proteolytic cleavage of the L1CAM adhesion molecule.

 

Autores e Afiliações:

The embryonic Brachyury transcription factor is a novel biomarker of GIST aggressiveness and poor survival

Authors and Affiliations:

Filipe Pinto1,2 Nathalia C. Campanella3 Lucas F. Abrahão-Machado4 Cristovam Scapulatempo-Neto3,4 Antonio T. de Oliveira3,5 Maria J. Brito6 Raquel P. Andrade7 Denise P. Guimarães3,8 Rui M. Reis1,2,3

 

1 Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal

2 ICVS/3B’s-PT Government Associate Laboratory, Braga, Guimara˜es, Portugal

O factor de transcrição embrionário Brachyury é um novo biomarcador de agressividade e pior prognóstico em tumores do estroma gastrointestinal (GIST)

O factor de transcrição Brachyury foi recentemente descrito como estando sobre-expresso e associado com pior prógnostico em tumores sólidos. No presente estudo avaliamos o potencial valor de prognóstico de Brachyury em tumores do estroma gastrointestinal (GIST).

miR-29b moulds the tumour microenvironment to repress metastasis

Authors and affilliations:

Melo SA, Kalluri R.

Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 

 

 

Abstract:

miR-29b moulds the tumour microenvironment to repress metastasis

Autores e afiliações:

Melo SA, Kalluri R.

Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 

 

 

Resumo: